Xatral SR


What it is used for

Indicated for the treatment of the functional symptoms of benign prostatic hyperplasia..


How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

  • Store below 25 degrees Celsius
  • Shelf lifetime is 3 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems


How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

  • Store below 25 degrees Celsius
  • Shelf lifetime is 3 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Pregnant or planning a pregnancy?

For the active ingredient alfuzosin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.


Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.


Visual appearance

ROUND, BICONVEX, THREE-LAYER TABLET: ONE WHITE LAYER BETWEEN TWO YELLOW LAYERS.


Is this medicine subsidised?

This medicine was verified as being available on the Repatriation Schedule of Pharmaceutical Benefits (RPBS) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

To access RPBS medicines you must hold a DVA Gold Card, DVA Orange Card or DVA White Card (for some medicines only). To learn about Department of Veterans’ Affairs health cards, visit Department of Veterans’ Affairs.

0 0 votes
Do you use this medicine? Rate it:
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments